Five Minutes with Dr Deborah O’Neil | The Post-Antibiotic Era

Dr Deborah O’Neil is the CEO of Novabiotics, a leading clinical-stage biotechnology company focused on the design and development of first-in-class anti-infectives. She recently delivered a talk on the pharmaceutical industry as it is today, and offered an insight into what it could become, with a focus on so-called ‘personalised medicines’. She also addressed the worrying issue of antimicrobial resistance and discussed new cancer therapies being approved by the NHS. This is Five Minutes with Dr Deborah O'Neil.